Tech Company Financing Transactions

Crescendo Bioscience Funding Round

Aeris Capital AG, Kleiner Perkins Caufield & Byers and Mohr Davidow Ventures joined a $31 million Series C venture round for Crescendo Bioscience. The round was announced on 9/8/2011.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

341 Oyster Point Blvd
South San Francisco, CA 94080
USA

Phone

(650) 351-1354

Website

www.crescendobio.com

Email Address

Not Recorded

Overview

Crescendo Bioscience is developing a broad range of quantitative, objective diagnostic tools to provide Rheumatologists with deeper clinical insights to more effectively manage patients with autoimmune and inflammatory diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

William Hagstrom

        

Chief Information Officer

Alex Bangs

        

Chief Medical Officer

Oscar Segurado

        

Chief Operating Officer

Brian Bertha

        

VP - Bus. Development

Lucy Lu

        

VP - Finance

Timothy Henn

        

VP - Sales

Erik Harris

        

Browse more venture capital transactions:

Prev: 9/8/2011: HookLogic venture capital transaction
Next: 9/8/2011: Wildcat Discovery Technologies venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary